Related Experiment Video
Updated: Jun 17, 2026
11:49
Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application
Published on: March 8, 2019
Follicular Fluid Meiosis-Activating Sterol (FF-MAS) Enhances Lens Transparency By Increasing αA-Crystallin Solubility
Si Chen1, Linlin Luo1, Xue Li1
1Department of Ophthalmology, Daping Hospital, Army Medical Center of the People's Liberation Army, Third Military Medical University (Army Medical University).
Journal of Visualized Experiments : Jove
|June 15, 2026
Summary
FF-MAS, synthesized by CYP51, reduces crystallin aggregation and improves lens transparency, offering a potential new treatment for cataracts. This finding highlights FF-MAS
Area of Science:
- Ophthalmology
- Biochemistry
- Molecular Biology
Background:
- Cataracts are characterized by crystallin insolubility and aggregation.
- CYP51 is a candidate gene for cataracts, but its role is unconfirmed.
- FF-MAS, synthesized by CYP51, is investigated for its impact on lens health.
Purpose of the Study:
- To investigate the role of FF-MAS in αA-crystallin solubility and lens transparency.
- To determine if FF-MAS can prevent or alleviate cataract formation.
- To explore the therapeutic potential of FF-MAS for cataracts.
Main Methods:
- Administered FF-MAS to HLE-B3 cells and rats with selenite-induced cataracts.
- Assessed lens transparency using slit-lamp photography.
- Analyzed lens uniformity, αA-crystallin aggregation, apoptosis, and antioxidant capacity.
Main Results:
- FF-MAS reduced αA-crystallin (R116C) aggregation in cells.
- In rats, FF-MAS increased αA-crystallin solubility and lens transparency.
- Inhibition of CYP51 induced cataracts, while FF-MAS supplementation prevented this.
Conclusions:
- FF-MAS plays a significant role in maintaining αA-crystallin solubility and lens transparency.
- Elevating FF-MAS levels may offer a novel approach for cataract prevention and treatment.
- This study provides evidence for FF-MAS as a therapeutic target for cataracts.
